Biotechnology Portfolio Biotechnology Fund Analysis

Biotechnology Mutual Fund Analysis Notes

The fund generated returns of 6.0% over the last ten years. Biotechnology Portfolio retains 96.05% of assets under management (AUM) in equities. This fund last dividend was 0.03 per share. Large To learn more about Biotechnology Portfolio Biotechnology call the company at 800-544-8544.

Biotechnology Portfolio Investment Alerts

Biotechnology Portfolio Thematic Classifications

Biotechnology Market Capitalization

The company currently falls under '' category with a current market capitalization of 0. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotechnology Portfolio's market, we take the total number of its shares issued and multiply it by Biotechnology Portfolio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Top Biotechnology Portfolio Biotechnology Mutual Fund Constituents

Technical Drivers

As of the 2nd of December, Biotechnology Portfolio shows the Standard Deviation of 1.27, risk adjusted performance of (0.01), and Mean Deviation of 0.9089. Biotechnology Portfolio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.

Biotechnology Portfolio Price Movement Analysis

Biotechnology Portfolio Outstanding Bonds

Biotechnology Portfolio Predictive Daily Indicators

Biotechnology Portfolio Forecast Models

Biotechnology Portfolio's time-series forecasting models are one of many Biotechnology Portfolio's mutual fund analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotechnology Portfolio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Mutual Fund analysis is the technique used by a trader or investor to examine and evaluate how Biotechnology Portfolio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotechnology shares will generate the highest return on investment. We also built our fund analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Fund such as Biotechnology Portfolio. By using and applying Biotechnology Mutual Fund analysis, traders can create a robust methodology for identifying Biotechnology entry and exit points for their positions.

Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.